Literature
首页医源资料库在线期刊美国临床营养学杂志2003年77卷第5期

Postprandial effects of dietary trans fatty acids on apolipoprotein(a) and cholesteryl ester transfer

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:Theconsumptionoftransfattyacidsadverselyaffectsfastingplasmalipoproteinconcentrations。Objective:Thisstudyaimedtoinvestigatewhetherpostprandiallipoproteinmetabolismisaffectedbytheconsumptionoftransfattyacids。Design:Inarandomizedcrossoverstu......

点击显示 收起

Lissa M Gatto, David R Sullivan and Samir Samman

1 From the Human Nutrition Unit, School of Molecular and Microbial Biosciences, University of Sydney; Sydney, Australia (LMG and SS), and the Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (DRS).

2 Supported by grants from the University of Sydney Nutrition Research Foundation.

3 Address reprint requests to S Samman, Human Nutrition Unit, School of Molecular and Microbial Biosciences, University of Sydney, Sydney, New South Wales 2006, Australia. E-mail: s.samman{at}mmb.usyd.edu.au.


ABSTRACT  
Background: The consumption of trans fatty acids adversely affects fasting plasma lipoprotein concentrations.

Objective: This study aimed to investigate whether postprandial lipoprotein metabolism is affected by the consumption of trans fatty acids.

Design: In a randomized crossover study, 19 healthy men consumed fatty meals that were identical except that 10% of energy was provided as trans 18:1 acids in the trans meal and as oleic acid in the cis meal.

Results: The meals induced similar responses in plasma lipids. Cholesteryl ester transfer (CET) was activated after consumption of both meals (P < 0.0001); however, it was 28% higher after the trans meal than after the cis meal (280 ± 129 compared with 219 ± 116 nmol cholesteryl ester/mL plasma • 6 h; time x diet interaction: P < 0.0001). Plasma apolipoprotein(a) [apo(a)] concentrations remained constant; however, triacylglycerol-rich lipoproteins formed 4 h after ingestion of the trans meal contained a higher concentration of apo(a) than did those formed after ingestion of the cis meal (48.9 ± 6.6 compared with 39.6 ± 5.4 U/L; P < 0.02). The change in CET and in the proportion of plasma apo(a) in the triacylglycerol-rich lipoprotein fractions correlated with indexes of alimentary lipemia.

Conclusions: Consumption of meals high in trans fatty acids results in higher CET and postprandial lipoprotein concentrations enriched in apo(a) than does consumption of meals free of trans fatty acids. This study highlights the importance of double-bond configuration in determining postprandial lipoprotein composition.

Key Words: Postprandial lipemia • trans fatty acids • apolipoprotein(a) • cholesteryl ester transfer • men


INTRODUCTION  
Partial hydrogenation techniques to convert some of the cis fatty acids in oils and marine fats into trans fatty acids (TFA) or saturated fatty acids (SFAs) have dramatically increased the availability of TFAs in the food supply. Ecologic studies (1–5) suggest that the consumption of TFAs is positively associated with ischemic heart disease (IHD) risk, and increasing public health concerns (6) have prompted the production of margarines with minimal TFA concentrations. Despite efforts to reduce the amount of TFAs in the food supply, partially hydrogenated fats continue to feature in the production of many foods, particularly baked and fast-food products.

Studies in humans (7–16) and animals (17) suggest that the increased risk of IHD associated with TFA intake involves elevations in both apolipoprotein(a) [apo(a)] concentrations and the ratio of LDL to HDL cholesterol. High concentrations of apo(a) (18, 19) and LDL cholesterol (20, 21) and low concentrations of HDL cholesterol (20, 22) in fasting plasma are important independent predictors of IHD risk; however, only a small proportion of the day is spent in the fasting state. The typical Western diet is characterized by the regular consumption of energy-dense meals; therefore, the metabolically postprandial state usually predominates.

The idea that postprandial lipoproteins play a significant role in the progression of atherosclerotic lesions is not new (23, 24); however, triacylglycerol-rich lipoproteins (TRLs) were previously considered too large to penetrate arterial tissue. Chylomicron remnants can diffuse through arterial tissue in a rapid nonspecific manner and become preferentially trapped within the subendothelial space as concentrated focii (25). In addition, there is a growing number of reports that provide strong evidence that postprandial TRLs are involved in atherogenesis (26–29).

Although the fatty acid composition of individual meals has been shown to be a determinant of the plasma TRL response (30), the postprandial effects of consuming high-TFA meals are poorly understood. Therefore, this study aimed to compare the acute effects of ingesting meals high in TFAs with the effects of meals high in oleic acid on aspects of postprandial lipoprotein metabolism. Particular attention was directed toward differential effects on postprandial plasma and TRL lipid and apo(a) concentrations and cholesteryl ester transfer (CET).


SUBJECTS AND METHODS  
Subjects
Volunteers were screened to exclude persons with the apolipoprotein E2/E2 genotype, plasma apo(a) concentrations < 30 mg/L, diabetes mellitus, abnormal liver function, and a body mass index (in kg/m2) > 30 and those persons taking medications or nutritional supplements known to affect lipoprotein metabolism. Nineteen volunteers with a mean (± SD) age of 29.0 ± 7.8 y and a body mass index of 24.8 ± 2.8 were accepted into the study. The subjects’ fasting baseline lipid and lipoprotein concentrations (mmol/L) were as follows: triacylglycerol, 1.2 ± 0.3; total cholesterol, 4.8 ± 0.8; HDL cholesterol, 1.2 ± 0.3; and LDL cholesterol, 3.2 ± 0.8. The median apo(a) concentration was 130 mg/L (range: 37–634 mg/L). The distribution of apo E genotypes among the subjects was as follows: E3/E3 (n = 9), E3/E4 (n = 6), and E2/E3 (n = 4). The volunteers accepted into the study were requested to maintain their habitual diet and exercise regimens. The protocol was approved by The Sydney University Human Ethics Review Committee.

Study design
A randomized crossover design was used to compare aspects of the postprandial response to a challenge meal containing TFAs (trans meal) with those to a control meal containing cis fatty acids (cis meal). On 2 occasions 2 wk apart, the subjects reported in a fasting (12 h) state to a metabolic unit, where a baseline (0 h) blood sample was collected. The subjects were then provided with either the trans or cis meal and were requested to consume the entire amount within 10 min. Additional blood samples were collected 4, 6, and 8 h postprandially. The subjects remained sedentary during the tests and were allowed water only.

Test meals
The test meals provided 49.4 kJ/kg body wt and contained 75% of total energy from fat, 20% from carbohydrate, and 5% from protein. The test meal provided 0.14 mg cholesterol/kg body wt and 1 g fat/kg body wt. The meals were identical in composition, except that 10% of energy was provided as trans 18:1 fatty acids in the trans meal and as oleic acid in the cis meal. The TFA was a commercially available TFA-containing margarine (Gold’n Canola; Meadow Lea Foods, Mascot, Australia), whereas the cis fatty acid was a blend of canola, olive, and palm oils (Meadow Lea Foods). The fat content of the meals was almost exclusively (99.5%) derived from test fats. The ratio of SFAs to monounsaturated fatty acids (MUFAs) to polyunsaturated fatty acids (PUFAs) in the meals was 0.69:3.08:1.00 and 0.62:2.87:1.00 in the cis and trans meals, respectively. The cis meal contained 62.4% of fatty acids as oleic acid (cis-18:1) and was devoid of trans 18:1 fatty acids, whereas the trans meal contained 51.7% of fatty acids as oleic acid and 9.9% as trans 18:1. Both fats contained small amounts of trans 16:1 (< 0.01% total fatty acids) and trans 18:2 isomers (< 0.50% total fatty acids). In calculating the ratio of fatty acid classes, trans fatty acids were included with the monounsaturates.

Meals were prepared by combining an amount of oil blend containing 1 g/kg fat with 2.96 mL/kg skim milk (Dairy Farmers, Sydney) with 0.43 g/kg condensed skim milk (Carnation Inc, Bathurst) and 0.43 g/kg chocolate topping (Mynor Chocolate Topping; Schweppes Cottee’s, Melbourne) in a blender and presented to the subjects as a warm chocolate-flavored beverage.

Blood collection and processing
The subjects rested in a seated position for 15 min before each blood sample was obtained. Between blood samplings, the subjects were allowed to walk within a restricted area of the Metabolic Unit, read, or watch videos. Blood was drawn into EDTA-coated tubes, and plasma was recovered immediately by centrifugation (1000 x g, 15 min, 4 °C). The rate of CET was determined in fresh plasma supplemented with sodium azide, Trasylol (Bayer AG, Leverkusen, Germany), and Paraoxan (Sigma, St Louis) at final concentrations of 1 mmol/L, 50 U/mL, and 2 mmol/L, respectively.

Lipid and apolipoprotein(a) measurements
The concentrations of total cholesterol, free cholesterol, and triacylglycerol in plasma and the d (density) < 1.006 (TRL) and > 1.006 g/mL fractions were determined with the use of enzymatic techniques: cholesterol by CHOD-PAP and triacylglycerol with Unimate 5 (Roche, Basel, Switzerland) and free cholesterol with a method developed by Boehringer Mannheim, Mannheim, Germany. Cholesteryl ester (CE) concentrations were calculated by difference. HDL-cholesterol concentrations were measured after the precipitation of apo B–containing lipoproteins (31). Apo(a) was measured by radioimmunoassay (Mercodia, Uppsala, Sweden), and apo E genotyping was performed by restriction fragment length polymorphism gel electrophoresis. The CV for all assays was < 5%.

Lipoprotein isolation
TRLs (d < 1.006 g/mL) were isolated by ultracentrifugation (200 000 x g, 16 h, 4 °C) in a 50.4 rotor (Beckman, Palo Alta, CA) on 2 separate occasions. First, lipoprotein fractions for lipids and CET assays were obtained by ultracentrifugation of fresh (unfrozen) plasma. Second, ultracentrifugation of a frozen aliquot was carried out for the analysis of apo(a). All samples obtained from an individual subject were assayed in the same run; > 95% (n = 19) of total cholesterol and triacylglycerol were recovered from plasma.

Net cholesteryl ester transfer to triacylglycerol-rich lipoproteins
The net mass transfer of CE from lipoprotein fractions with a d > 1.006 g/mL to TRLs was measured in plasma collected at 0 and 6 h as described previously (32). Briefly, duplicate aliquots (4 mL) of plasma were either kept on ice (control tubes) or incubated (6 h, 37 °C, pH 7.4) in a shaking water bath to activate the CET protein reaction. After ultracentrifugation (200 000 x g, 16 h, 4 °C, 50.4 rotor), both TRL fractions were assayed in triplicate for total cholesterol and free cholesterol. The TRL-CE value obtained from the control tube (incubated at 4 °C) was subtracted from the TRL-CE value incubated at 37 °C, and the results were expressed as nmol CE transferred/mL plasma in a 6-h incubation (nmol/mL plasma • 6 h). The CV of the 2 methods (cholesterol and free cholesterol concentrations) is < 3%. In pilot studies, we showed that CET is linear over 6 h at baseline triacylglycerol concentrations in the range of 1.05–5.40 mmol/L.

Apolipoprotein(a) in the d < 1.006 and d > 1.006 g/mL fractions
The total plasma concentration and distribution of apo(a) in the d < 1.006 and d > 1.006 g/mL fractions were determined at 0 and 4 h. Aliquots (4 mL) of plasma were ultracentrifuged as described above, and the d < 1.006 g/mL fractions were recovered. The analysis of apo(a) concentrations was performed in duplicate.

Statistical analyses
Comparisons between test meal data were carried out by using a two-factor repeated-measures general linear model with Greenhouse-Geisser adjustments for asphericity where necessary. P values for the effects of diet, time, and time x diet interaction were obtained. When a significant time x treatment effect was detected, specific effects were located by pairwise comparisons with a Bonferroni adjustment for multiple comparisons. Apo(a) data were analyzed with the use of Wilcoxon’s matched-pairs signed-rank test. Correlations between variables were assessed with the use of Pearson’s correlation coefficients. Analyses were performed with SPSS for WINDOWS (version 10; SPSS Inc, Chicago), and significance was set at P < 0.05. The data are presented as means ± SDs, except where noted otherwise.


RESULTS  
All subjects who qualified for entry completed the study. The change in body weight between visits was an increase of 1.0 ± 0.1 kg.

Plasma and TRL concentrations
The subjects’ fasting total cholesterol, HDL-cholesterol, CE, and triacylglycerol concentrations were not significantly different before the cis and trans test meals (Table 1). The meals elicited significant postprandial responses in plasma total cholesterol (P < 0.02), CE (P < 0.001), and triacylglycerol (P < 0.004) concentrations. HDL-cholesterol concentrations were not affected significantly. Plasma triacylglycerol was highest at 4 h, with concentrations being 2 times greater than fasting, and then decreased slightly to 1.5 times fasting concentrations by 6 h and then decreased to nearly fasting concentrations by 8 h. Plasma TRL concentrations are shown in Table 2. TRL-cholesterol and TRL-triacylglycerol concentrations were measured in fasting and 6-h postprandial plasma samples. Baseline concentrations were not significantly different, and both test meals resulted in increases in TRL-cholesterol (P < 0.001) and TRL-triacylglycerol (P < 0.001) concentrations.


View this table:
TABLE 1 . Plasma lipid concentrations in the fasting and postprandial states1  

View this table:
TABLE 2 . Triacylglycerol-rich lipoprotein (TRL) triacylglycerol and TRL-cholesterol concentrations in the fasting and postprandial states1  
Cholesteryl ester transfer
Rates of CET from lipoproteins in the d > 1.006 g/mL fraction to those in the d < 1.006 g/mL fraction were determined in fasting (0 h) and postprandial (6 h) samples. Fasting CET rates were similar in the cis and trans groups (147 ± 77 compared with 148 ± 73 nmol CE/mL • 6 h, respectively). Rates of CET from lipoproteins in the d > 1.066 g/mL fraction to TRLs were significantly higher 6 h after consumption of the cis and trans test meals than at baseline (219 ± 27 and 280 ± 30 nmol CE/mL • 6 h, respectively; P < 0.0001; Figure 1). The extent of the increase after the trans meal was significantly greater than that after the cis meal, as indicated by a significant time x diet interaction (P < 0.0001).


View larger version (26K):
FIGURE 1. . Mean (± SE) cholesteryl ester transfer (CET) from lipoproteins with a density > 1.006 g/mL to triacylglycerol-rich lipoproteins (density < 1.006 g/mL) in the fasting state and after the consumption of meals in which 10% of energy was provided as trans 18:1 acids (trans meal) or as oleic acid (cis meal). n = 19 healthy men. Significant time (P < 0.0001) and time x diet interaction (P < 0.0001). *Significantly different from the cis meal, P < 0.05.

 
CET was closely correlated with indexes of plasma lipemia (Table 3). CET correlated with plasma triacylglycerol and TRL-triacylglycerol in both the fasting and postprandial states. At 6 h after ingestion of the meals, the percentage increase in CET correlated positively with the percentage increase in plasma triacylglycerol and TRL-triacylglycerol. CET did not correlate with plasma total cholesterol or TRL-cholesterol concentrations.


View this table:
TABLE 3 . Relation between cholesteryl ester transfer (CET) (nmol CE/mL plasma • 6 h) and plasma triacylglycerol and triacylglycerol-rich lipoprotein triacylglycerol concentrations in the fasting and postprandial states1  
Apo(a) in plasma TRL and the d > 1.006 g/mL fraction
TRL-apo(a), expressed as the percentage change from baseline, correlated significantly with plasma triacylglycerol (r = 0.60, P < 0.0001), TRL-triacylglycerol (r = 0.77, P < 0.0001), and the percentage increase in plasma triacylglycerol (r = 0.69, P < 0.0001) at 4 h. Ingestion of the test meals altered the distribution of apo(a) within the plasma compartment. In fasting plasma, TRL-apo(a) expressed as a percentage of the plasma apo(a) concentration was not significantly different between the cis and trans meal groups. After consumption of the test meals (4 h), the percentage distribution of apo(a) in TRL increased significantly in the trans meal group compared with the cis meal group (P = 0.005; Figure 2). This redistribution was confirmed by a significant reduction in the concentration of apo(a) in the d > 1.006 g/mL fraction (P < 0.02; Figure 2). Together, these results indicate that the consumption of the trans meal resulted in a greater apo(a) redistribution from the d > 1.006 g/mL fraction to the TRL fraction than did the consumption of the cis meal.


View larger version (29K):
FIGURE 2. . Mean (± SE) percentage of total plasma apolipoprotein(a) [apo(a)] in triacylglycerol-rich lipoprotein [TRL; density (d) < 1.006 g/mL] and in plasma fractions with a d > 1.006 g/mL in the fasting state and after the consumption of meals in which 10% of energy was provided as trans 18:1 acids (trans meal) or as oleic acid (cis meal). n = 19 healthy men. *Significantly different from the cis meal at same time, P < 0.05.

 

DISCUSSION  
Research into the mechanisms underlying the increased risk of IHD associated with consumption of high-TFA diets suggests that the effects are multifactorial. Two key factors have been identified. First, the consumption of TFA-rich diets increases the fasting plasma CET protein activity relative to other major dietary fatty acids (17, 33–35). Although many other factors, such as lipoprotein receptor activity and rates of lipoprotein secretion, could be involved, studies showing increased fasting ratios of LDL to HDL cholesterol after short-term consumption of high-TFA diets (7–10, 12–17) support a role for TFA in regulating CET protein activity. Second, diets rich in TFAs have been shown to increase plasma apo(a) compared with diets containing similar amounts of oleic acid (11, 13, 17), stearic acid (1), palmitic acid (13, 17), or SFA combinations (11, 13, 17). The findings of the present study show that an increase in CET and an enrichment of TRL with apo(a) occurs in the postprandial state to a greater extent after a meal that contains fat in the trans than in the cis configuration.

Postprandial lipemia induces the formation of TRLs with elevated rates of CET (36–38) and elevated apo(a) concentrations (39–41). The current study was designed to investigate the acute effects of meals high in either TFAs (trans meal) or oleic acid (cis meal) on lipid concentrations, CET, and the apo(a) content of TRLs. The timing of blood collection was designed to take advantage of the maximal remodeling of plasma lipoproteins 3–6 h after an oral fat load. The results suggest that ingestion of TFA-rich meals induces a greater postprandial increase in CET and TRL-apo(a) concentrations than do meals in which TFAs are replaced with oleic acid. Postprandial increases in CET and the proportion of total plasma apo(a) contained TRLs correlated closely with postprandial increases in plasma and TRL-triacylglycerol. This highlights the importance of double-bond configuration in determining the composition of postprandial lipoproteins and suggests that the increased risk of IHD associated with high TFA intakes includes adverse effects on postprandial lipoprotein metabolism.

The test meals used in the current study provided 1 g fat /kg body wt, which represents a serving of fat easily achieved in real-life settings. Ingestion of the cis and trans meals elicited similar postprandial responses in plasma triacylglycerol, TRL-triacylglycerol, total cholesterol, HDL cholesterol, and CE concentrations (Table 1). Peak plasma triacylglycerol and TRL-triacylglycerol concentrations were observed at 4 h, with concentrations increasing by 2-fold. Plasma triacylglycerol and TRL-triacylglycerol concentrations remained elevated at 6 h but approached fasting concentrations by 8 h. The postprandial increases in plasma and TRL-triacylglycerol observed in the current study are comparable with those observed in previous reports (36, 40, 41).

Fasting rates of CET from lipoproteins with a d > 1.006 g/mL to TRLs were not significantly different; however, ingestion of the trans meal resulted in significantly higher rates of CET in postprandial plasma than did the cis meal (increases of 102 ± 68% and 68 ± 52%, respectively; Figure 1). The postprandial elevations in CET are similar to the elevations observed in previous reports in healthy (37) and hypercholesterolemic (36) subjects fed similar oral fat loads. CET was correlated with plasma triacylglycerol and TRL-triacylglycerol in both the fasting and postprandial states (Table 3). Postprandially, the percentage increase in CET was most closely correlated with the percentage increase in plasma triacylglycerol and TRL-triacylglycerol (Table 3). These findings agree with those of previous studies, ie, the plasma triacylglycerol concentration is the major factor determining the extent of postprandial CET activation (36–38), whereas the fatty acid composition of TRL has less of an effect (37).

Increases in the plasma CETP concentration have also been implicated in both the postprandial stimulation of CET (38) and in elevated fasting plasma CETP activity after the consumption of TFA-rich diets (34); however, this was not investigated in the current study. The increase in postprandial CET after ingestion of the trans meals in the current study is comparable with increases in fasting CET activities reported in other short-term feeding trials (33, 34). The similar plasma triacylglycerol and TRL-triacylglycerol responses to the cis and trans meals together with the lack of an association of CET with the concentration of TFA in TRL support the notion that increased CETP mass may account for increases in CETP activity.

Total plasma apo(a) concentrations in fasting and postprandial plasma were not significantly different after the cis or trans meals; however, consumption of the oral fat loads altered the distribution of apo(a) within the lipoprotein fractions. The percentage of total plasma apo(a) in the TRL fraction in fasting plasma was also similar; however, ingestion of the trans meal resulted in the formation of a TRL fraction containing a significantly higher (P < 0.005) proportion of total plasma apo(a) relative to the cis meal. Similarly, reciprocal changes in apo(a) were detected in the d > 1.006 g/mL lipoprotein fraction. Together, these data suggest that elevations in TRL-apo(a) concentrations after an oral fat load are due to the redistribution of apo(a) or lipoprotein(a) from lipoproteins with a d > 1.006 g/mL to TRLs rather than to an increase in the production of apo(a). These data corroborate similar findings from previous work in which the acute effects of equivalent oral fat loads were investigated (40, 41). In addition, the findings of the current study provide new evidence suggesting that the consumption of TFA-containing meals results in TRLs that contained more apo(a) than did the consumption of TFA-free meals.

The percentage of total plasma apo(a) in TRLs and the percentage increase in TRL-apo(a) were closely correlated with 4-h plasma triacylglycerol and TRL-triacylglycerol concentrations and with the percentage increase in plasma triacylglycerol and TRL-triacylglycerol. In contrast, the correlations between plasma total apo(a) and TRL-apo(a)—expressed as the absolute concentration or the change in concentration 4 h postprandially—were much weaker (r 0.37, P < 0.05). Postprandial increases in TRL-apo(a) did not correlate significantly with increases in CET, suggesting that many factors may be involved in the 2 processes.

Marcoux et al (42) showed that postprandial TRLs contained a much smaller proportion (5%) of total plasma apo(a) than observed in the current study and in other studies (40, 41). These differences may have been due to the smaller fat load administered, to the earlier timing of blood collection, or to the different method of preparing the TRL fraction. Despite these differences, characterization of 3-h postprandial TRLs showed apo(a) to be associated with lipoproteins intermediate in size between VLDLs and LDLs, consistent with it being apo(a) (42). Apo(a) was also easily dissociated from TRL lipids, suggesting that increases in TRL-apo(a) are the result of noncovalent binding of lipoprotein(a) to TRL during alimentary lipemia.

In addition to being associated with TRLs, apo(a) has also been isolated from human atherosclerotic plaque (43–46), possibly in association with proteoglycans (46). This could allow for the accumulation of lipoprotein(a) at the site of vessel injury, where it may undergo oxidative modification and become a ligand for the scavenger receptor on macrophages (47), thereby contributing to foam cell formation (48). The elevated concentration of apo(a) in TRLs after meals enriched in TFAs may therefore enhance the involvement of TRLs in atherogenesis.

In summary, our data provide insight into the role of TFAs in regulating lipoprotein metabolism. The consumption of meals in which cis fatty acids (oleic acid) are replaced with trans fatty acids results in elevations in CET and in the formation of TRLs, which are relatively enriched in apo(a). The findings of the current study suggest that frequent ingestion of foods that contain TFAs has deleterious consequences on the composition of postprandial lipoprotein particles, which may enhance their atherogenicity.


REFERENCES  

  1. Aro A, Kardinaal AF, Salminen I, et al. Adipose tissue isomeric trans fatty acids and the risk of myocardial infarction in nine countries: the EURAMIC study. Lancet 1995;345:273–8.
  2. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC. Trans fatty acids intake and risk of myocardial infarction. Circulation 1994;89:94–101.
  3. Siguel EN, Lerman RH. Trans fatty acid patterns in patients with angiographically documented coronary artery disease. Am J Cardiol 1993;71:916–20.
  4. Thomas LH, Winter JA, Scott RG. Concentration of 18:1 and 16:1 transunsaturated fatty acids in the adipose body tissue of decedents dying of ischaemic heart disease compared with controls: analysis by gas liquid chromatography. J Epidemiol Community Health 1983;37:16–21.
  5. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993;341:581–5.
  6. Willett WC, Ascherio A. Trans fatty acids: are the effects only marginal? Am J Public Health 1994;84:722–4.
  7. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 1994;59:861–8.
  8. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999;340:1933–40.
  9. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas JM, Schaefer EJ. Hydrogenation impairs the hypolipidaemic effect of corn oil in humans: hydrogenation, trans fatty acids and plasma lipids. Arterioscler Thromb 1993;13:154–61.
  10. Mensink RP, Katan MB. Effect of dietary trans fatty acid level on high density and low density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439–45.
  11. Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J lipid Res 1992;33:1493–501.
  12. Nestel PJ, Noakes M, Clifton PM. Fats for the food industry: implications for cholesterol-lowering. Lipids 1996;31:S65–9.
  13. Nestel PJ, Noakes M, Belling GB, et al. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992;33:1029–36.
  14. Nestel PJ, Noakes M, Belling GB, McArthur R, Clifton PM, Abbey M. Plasma cholesterol-lowering potential of edible-oil blends suitable for commercial use. Am J Clin Nutr 1992;55:46–50.
  15. Noakes M, Clifton PM. Oil blends containing partially hydrogenated or interesterified fats: differential effects on plasma lipids. Am J Clin Nutr 1998;68:242–7.
  16. Sundram K, Ismail A, Hayes KC, Jeyamalar R, Pathmanathan R. Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J Nutr 1997;127:S514–20.
  17. Khosla P, Hajri T, Pronczuk A, Hayes KC. Replacing dietary palmitic acid with elaidic acid (t-C18:19) depresses HDL and increases CETP activity in cebus monkeys. J Nutr 1997;127:S531–6.
  18. Wild SH, Fortmann SP, Marcovina SM. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City project participants. Arterioscler Thromb Vasc Biol 1997;17:239–45.
  19. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990;301:1248–51.
  20. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 1992;2:23–8.
  21. Hargreaves AD, Logan RL, Thomson M, Elton RA, Oliver MF, Riemersma RA. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland. BMJ 1991;303:678–81.
  22. Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 1990;86:379–84.
  23. Albrink MJ, Man EB. Serum triglycerides in coronary artery disease. Arch Intern Med 1959;103:4–8.
  24. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473–85.
  25. Proctor SD, Mamo JCL. Arterial fatty lesions have increased uptake of chylomicron remnants but not low density lipoprotein. Coronary Artery Dis 1996;7:239–45.
  26. Ginsberg HN, Jones J, Blaner WS, et al. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle aged men and women. Arterioscler Thromb Vasc Biol 1995;15:1829–38.
  27. Sharrett AR, Chambless LE, Heiss G, Paton CC, Patsch W. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle aged men and women. Arterioscler Thromb Vasc Biol 1995;15:2122–9.
  28. Weintraub MS, Grosskopf I, Rassin T, et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996;312:936–9.
  29. Uiterwaal CSPM, Grobbee DE, Witteman JCM, et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994;121:576–83.
  30. Williams CM. Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis 1998;141:S87–92.
  31. Warnick GR, Benderson J, Albers JJ. Dextran sulphate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379–88.
  32. Contacos C, Barter PJ, Vrga L, Sullivan DR. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. Atherosclerosis 1998;141:87–98.
  33. Abbey M, Nestel PJ. Plasma cholesteryl ester transfer protein activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet. Atherosclerosis 1994;106:99–107.
  34. van Tol A, Zock PL, van Gent T, Scheek LM, Katan MB. Dietary trans fatty acids increase serum cholesteryl ester transfer protein activity in man. Atherosclerosis 1995;115:129–34.
  35. Lagrost L. Differential effects of cis and trans fatty acid isomers, oleic and elaidic acids, on cholesteryl ester transfer protein activity. Biochim Biophys Acta 1992;1124:159–62.
  36. Lottenberg AMP, Nunes VS, Lottenberg SA, et al. Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effect of the degree of saturation of dietary fatty acids in the fasting and postprandial states. Atherosclerosis 1996;126:265–75.
  37. Tall AR, Sammett D, Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest 1986;77:1163–72.
  38. Castro GR, Fielding CJ. Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest 1985;75:874–82.
  39. Bersot TP, Innerarity TL, Pitas RE, Rall SC, Weisgraber KH, Mahley RW. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein(a) and that cause lipid accumulation in macrophages. J Clin Invest 1986;77:622–30.
  40. Cohn JS, Lam CWK, Sullivan DR, Hensley WJ. Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states. Atherosclerosis 1991;90:59–66.
  41. Sullivan DR, Lam CWK, Jessup W, Dean RT, Hensley WJ. Postprandial changes in apolipoprotein(a) concentration of triglyceride rich lipoproteins can be reproduced by in vitro incubation: implications for underlying mechanism. Atherosclerosis 1993;103:139–47.
  42. Marcoux C, Lussier-Cacan S, Davignon J, Cohn JS. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects. Biochim Biophys Acta 1997;1346:261–74.
  43. Reblin T, Meyer N, Labeur C, Henne-Bruns D, Beisiegel U. Extraction of lipoprotein(a), apoB and apoE from fresh human arterial wall and atherosclerotic plaques. Atherosclerosis 1995;113:179–88.
  44. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantitation of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989;9:579–92.
  45. Klezovitch O, Edelstein C, Zhu L, Scanu AM. Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. J Biol Chem 1998;272:23856–65.
  46. Haberland ME, Fless GM, Scanu AM, Fogelman AM. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. J Biol Chem 1992;267:4143–51.
  47. Bottalico LA, Keesler GA, Fless GM, Tabas I. Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apolipoprotein(a) internalisation and degradation. J Biol Chem 1993;268:8569–73.
  48. Nielsen LB, Juul K, Nordestgaard BG. Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation. Arterioscler Thromb Vasc Biol 1998;18:641–9.
Received for publication December 5, 2001. Accepted for publication September 20, 2002.


作者: Lissa M Gatto
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具